Director Mark Chin resigns from Iterum board effective Dec 31, 2023

Iterum Therapeutics plc

Mark Chin notified Company on Dec 28, 2023 of resignation from Board effective Dec 31.
Resignation due to desire to reduce public board commitments because of new job.
No disagreement with Company's operations, policies, or practices cited.
Chin served on Board for over six and a half years; Company thanked him.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Chin

member of the Board of Directors

ITRMF · Iterum Therapeutics plc

Effective: 2023-12-31
Filed: December 29, 2023, 6:59 PM ET

On December 28, 2023, Mark Chin informed management that he would be resigning as a member of the Board of Directors of Iterum Therapeutics plc (the "Company") with effect from December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Chin resigned as member of the Board of Directors at Iterum Therapeutics plc.

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On December 28, 2023, Mark Chin informed management that he would be resigning as a member of the Board of Directors of Iterum Therapeutics plc (the "Company") with effect from December 31, 2023.

View on SEC.gov

Iterum Therapeutics plc filing history →

Source: SEC EDGAR

accession 0000950170-23-073865

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.